Aroa’s Symphony may hit the right note in RFK Jnr's Medicare overhaul

Aroa’s Symphony may hit the right note in RFK Jnr's Medicare overhaul
Aroa chief executive Brian Ward says the company is encouraged by planned changes to Medicare billing for skin substitutes. (Image: NZME/Getty/Jacques Steenkamp/Supplied)
Rebecca Stevenson
Auckland-based med tech firm Aroa could be the winner from proposed changes to how the United States' Medicare pays for outpatient wound care, a new report says. Aroa, which is listed on the ASX, utilises sheep stomachs to produce wound repair products that aid in healing chronic wounds, hernias, soft tissue injuries, and for breast reconstruction. A new report by Wilsons Advisory said Aroa Biosurgery was best placed to gain from the Centers for Medicare and Medicaid Services’ (CMS) draft proposal to pay a flat rate for...

More Markets

Nvidia slump drags Wall Street and NZ sharemarket lower
Markets Market Close

Nvidia slump drags Wall Street and NZ sharemarket lower

The S&P/NZX 50 Index closed 20 points or 0.15% down at 13,419.40.

Jamie Gray 21 Nov 2025
RBNZ reopens Wellington office after asbestos mayhem
Finance

RBNZ reopens Wellington office after asbestos mayhem

Bank tight-lipped on how many staff are home-working as asbestos-hit office reopens. 

Andy Macdonald 21 Nov 2025
Oceania Healthcare extends dividend freeze
Markets

Oceania Healthcare extends dividend freeze

The retirement village operator hasn't paid a dividend since June 2023.

John Anthony 21 Nov 2025